Junki Ishii
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Junki Ishii has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Nobuaki Shime
Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan
7 shared publications - Shinichiro Ohshimo
Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan
4 shared publications - Mitsuaki Nishikimi
Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan; Department of Emergency and Critical Care Medicine, Aichi Medical University, Nagakute, Japan
3 shared publications Akihiro Takaba
JA Hiroshima General Hospital, Hiroshima, Japan
1 shared publication- Akira Kuriyama
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada
1 shared publication Atsuko Kobayashi
Takarazuka City Hospital, Hyogo, Japan
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1)
Impact of Preceding Chest CT on Functional Malpositioning of Chest Tubes in Traumatic Pneumothorax and Hemopneumothorax
Background: It remains controversial whether the lateral or the anterior approach is optimal for chest tube insertion in patients with traumatic pneumothorax (PTH). Objectives: This study aimed to evaluate the incidence of functional malpositioning of chest tubes inserted via the lateral versus anterior approach in patients with traumatic pneumothorax (PTH) and/or hemopneumothorax (HPTH), with or without a preceding CT examination. Methods: We conducted a two‐center, retrospective, observational study of consecutive patients treated with a chest tube for traumatic PTH/HPTH between August 2012 and September 2021. Patients were divided into two groups according to the presence or absence of CT examination before chest tube insertion: CT(+) or CT(−) group. In each group, the risk of functional malpositioning was compared between the lateral and anterior approaches. Results: Among 388 patients, 271 patients were analyzed. The CT(+) group comprised 200 (74%) patients, while the CT(−) group comprised 71 (26%) patients. The adjusted odds ratio of functional malpositioning with the lateral approach was 1.38 (95% confidence interval 0.64–2.98, p = 0.41) in the CT(+) group and 9.24 (95% confidence interval 1.49–57.50, p < 0.01) in the CT(−) group. There was a trend suggesting that the risk of functional malposition of chest tubes associated with the lateral approach, compared with the anterior approach, was modified by the presence or absence of a preceding CT examination ( p interaction = 0.01). Conclusions: The occurrence of functional malpositioning of the chest tube in patients with traumatic PTH/HPTH was higher with the lateral approach in patients without a preceding CT examination.
- 1 January 2026
- Published by Wiley in Acute Medicine & Surgery
- Vol. 13 (1)
Open AccessImpact of Preceding Chest CT on Functional Malpositioning of Chest Tubes in Traumatic Pneumothorax and Hemopneumothorax
Background: It remains controversial whether the lateral or the anterior approach is optimal for chest tube insertion in patients with traumatic pneumothorax (PTH). Objectives: This study aimed to evaluate the incidence of functional malpositioning of chest tubes inserted via the lateral versus anterior approach in patients with traumatic pneumothorax (PTH) and/or hemopneumothorax (HPTH), with or without a preceding CT examination. Methods: We conducted a two‐center, retrospective, observational study of consecutive patients treated with a chest tube for traumatic PTH/HPTH between August 2012 and September 2021. Patients were divided into two groups according to the presence or absence of CT examination before chest tube insertion: CT(+) or CT(−) group. In each group, the risk of functional malpositioning was compared between the lateral and anterior approaches. Results: Among 388 patients, 271 patients were analyzed. The CT(+) group comprised 200 (74%) patients, while the CT(−) group comprised 71 (26%) patients. The adjusted odds ratio of functional malpositioning with the lateral approach was 1.38 (95% confidence interval 0.64–2.98, p = 0.41) in the CT(+) group and 9.24 (95% confidence interval 1.49–57.50, p < 0.01) in the CT(−) group. There was a trend suggesting that the risk of functional malposition of chest tubes associated with the lateral approach, compared with the anterior approach, was modified by the presence or absence of a preceding CT examination ( p interaction = 0.01). Conclusions: The occurrence of functional malpositioning of the chest tube in patients with traumatic PTH/HPTH was higher with the lateral approach in patients without a preceding CT examination.
- Open Access
- 2 July 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (7) , e0034224
No improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study
Whether empirical therapy with carbapenems positively affects the outcomes of critically ill patients with bacterial infections remains unclear. This study aimed to investigate whether the use of carbapenems as the initial antimicrobial administration reduces mortality and whether the duration of carbapenem use affects the detection of multidrug-resistant (MDR) pathogens. This was a post hoc analysis of data acquired from Japanese participating sites from a multicenter, prospective observational study [Determinants of Antimicrobial Use and De-escalation in Critical Care (DIANA study)]. A total of 268 adult patients with clinically suspected or confirmed bacterial infections from 31 Japanese intensive care units (ICUs) were analyzed. The patients were divided into two groups: patients who were administered carbapenems as initial antimicrobials (initial carbapenem group, n = 99) and those who were not administered carbapenems (initial non-carbapenem group, n = 169). The primary outcomes were mortality at day 28 and detection of MDR pathogens. Multivariate logistic regression analysis revealed that mortality at day 28 did not differ between the two groups [18 (18%) vs 27 (16%), respectively; odds ratio: 1.25 (95% confidence interval (CI): 0.59–2.65), P = 0.564]. The subdistribution hazard ratio for detecting MDR pathogens on day 28 per additional day of carbapenem use is 1.08 (95% CI: 1.05–1.13, P < 0.001 using the Fine-Gray model with death regarded as a competing event). In conclusion, in-hospital mortality was similar between the groups, and a longer duration of carbapenem use as the initial antimicrobial therapy resulted in a higher risk of detection of new MDR pathogens. IMPORTANCE: We found no statistical difference in mortality with the empirical use of carbapenems as initial antimicrobial therapy among critically ill patients with bacterial infections. Our study revealed a lower proportion of inappropriate initial antimicrobial administrations than those reported in previous studies. This result suggests the importance of appropriate risk assessment for the involvement of multidrug-resistant (MDR) pathogens and the selection of suitable antibiotics based on risk. To the best of our knowledge, this study is the first to demonstrate that a longer duration of carbapenem use as initial therapy is associated with a higher risk of subsequent detection of MDR pathogens. This finding underscores the importance of efforts to minimize the duration of carbapenem use as initial antimicrobial therapy when it is necessary.
- 2 July 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (7) , e0034224
Open AccessNo improvement in mortality among critically ill patients with carbapenems as initial empirical therapy and more detection of multi-drug resistant pathogens associated with longer use: a post hoc analysis of a prospective cohort study
Whether empirical therapy with carbapenems positively affects the outcomes of critically ill patients with bacterial infections remains unclear. This study aimed to investigate whether the use of carbapenems as the initial antimicrobial administration reduces mortality and whether the duration of carbapenem use affects the detection of multidrug-resistant (MDR) pathogens. This was a post hoc analysis of data acquired from Japanese participating sites from a multicenter, prospective observational study [Determinants of Antimicrobial Use and De-escalation in Critical Care (DIANA study)]. A total of 268 adult patients with clinically suspected or confirmed bacterial infections from 31 Japanese intensive care units (ICUs) were analyzed. The patients were divided into two groups: patients who were administered carbapenems as initial antimicrobials (initial carbapenem group, n = 99) and those who were not administered carbapenems (initial non-carbapenem group, n = 169). The primary outcomes were mortality at day 28 and detection of MDR pathogens. Multivariate logistic regression analysis revealed that mortality at day 28 did not differ between the two groups [18 (18%) vs 27 (16%), respectively; odds ratio: 1.25 (95% confidence interval (CI): 0.59–2.65), P = 0.564]. The subdistribution hazard ratio for detecting MDR pathogens on day 28 per additional day of carbapenem use is 1.08 (95% CI: 1.05–1.13, P < 0.001 using the Fine-Gray model with death regarded as a competing event). In conclusion, in-hospital mortality was similar between the groups, and a longer duration of carbapenem use as the initial antimicrobial therapy resulted in a higher risk of detection of new MDR pathogens. IMPORTANCE: We found no statistical difference in mortality with the empirical use of carbapenems as initial antimicrobial therapy among critically ill patients with bacterial infections. Our study revealed a lower proportion of inappropriate initial antimicrobial administrations than those reported in previous studies. This result suggests the importance of appropriate risk assessment for the involvement of multidrug-resistant (MDR) pathogens and the selection of suitable antibiotics based on risk. To the best of our knowledge, this study is the first to demonstrate that a longer duration of carbapenem use as initial therapy is associated with a higher risk of subsequent detection of MDR pathogens. This finding underscores the importance of efforts to minimize the duration of carbapenem use as initial antimicrobial therapy when it is necessary.
- Open Access
The Current Discussion Regarding End-of-Life Care for Patients with Out-of-Hospital Cardiac Arrest with Initial Non-Shockable Rhythm: A Narrative Review
Despite recent advances in resuscitation science, outcomes in patients with out-of-hospital cardiac arrest (OHCA) with initial non-shockable rhythm remains poor. Those with initial non-shockable rhythm have some epidemiological features, including the proportion of patients with a witnessed arrest, bystander cardiopulmonary resuscitation (CPR), age, and presumed etiology of cardiac arrest have been reported, which differ from those with initial shockable rhythm. The discussion regarding better end-of-life care for patients with OHCA is a major concern among citizens. As one of the efforts to avoid unwanted resuscitation, advance directive is recognized as a key intervention, safeguarding patient autonomy. However, several difficulties remain in enhancing the effective use of advance directives for patients with OHCA, including local regulation of their use, insufficient utilization of advance directives by emergency medical services at the scene, and a lack of established tools for discussing futility of resuscitation in advance care planning. In addition, prehospital termination of resuscitation is a common practice in many emergency medical service systems to assist clinicians in deciding whether to discontinue resuscitation. However, there are also several unresolved problems, including the feasibility of implementing the rules for several regions and potential missed survivors among candidates for prehospital termination of resuscitation. Further investigation to address these difficulties is warranted for better end-of-life care of patients with OHCA.
Open AccessThe Current Discussion Regarding End-of-Life Care for Patients with Out-of-Hospital Cardiac Arrest with Initial Non-Shockable Rhythm: A Narrative Review
Despite recent advances in resuscitation science, outcomes in patients with out-of-hospital cardiac arrest (OHCA) with initial non-shockable rhythm remains poor. Those with initial non-shockable rhythm have some epidemiological features, including the proportion of patients with a witnessed arrest, bystander cardiopulmonary resuscitation (CPR), age, and presumed etiology of cardiac arrest have been reported, which differ from those with initial shockable rhythm. The discussion regarding better end-of-life care for patients with OHCA is a major concern among citizens. As one of the efforts to avoid unwanted resuscitation, advance directive is recognized as a key intervention, safeguarding patient autonomy. However, several difficulties remain in enhancing the effective use of advance directives for patients with OHCA, including local regulation of their use, insufficient utilization of advance directives by emergency medical services at the scene, and a lack of established tools for discussing futility of resuscitation in advance care planning. In addition, prehospital termination of resuscitation is a common practice in many emergency medical service systems to assist clinicians in deciding whether to discontinue resuscitation. However, there are also several unresolved problems, including the feasibility of implementing the rules for several regions and potential missed survivors among candidates for prehospital termination of resuscitation. Further investigation to address these difficulties is warranted for better end-of-life care of patients with OHCA.
- Open Access
- 17 August 2022
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 115 (11) , 758-759
Purpura fulminans due to Rickettsia japonica
Junki Ishii, M.D, Daisuke Haratake, M.D, Masanori Ito, M.D., Ph.D, Nobuaki Shime, M.D., Ph.D; Purpura fulminans due to Rickettsia japonica, QJM: An Internationa
- 17 August 2022
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 115 (11) , 758-759
Open AccessPurpura fulminans due to Rickettsia japonica
Junki Ishii, M.D, Daisuke Haratake, M.D, Masanori Ito, M.D., Ph.D, Nobuaki Shime, M.D., Ph.D; Purpura fulminans due to Rickettsia japonica, QJM: An Internationa
- 1 October 2020
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 48 (10) , e984-e985
Early Tracheostomy in Brain Injury: More Details Are Needed for Seeking Best Practice
- 1 October 2020
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 48 (10) , e984-e985
Early Tracheostomy in Brain Injury: More Details Are Needed for Seeking Best Practice
- 12 March 2018
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (4) , 548-549
Target blood pressure for septic and vasodilatory shock: what is optimal?
- 12 March 2018
- Published by Springer Nature in Intensive Care Medicine
- Vol. 44 (4) , 548-549
Target blood pressure for septic and vasodilatory shock: what is optimal?
- 1 February 2018
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 46 (2) , e181-e182
Is Oxygenation Really an Intrinsic Predictive Factor of Mortality in Patients Undergoing Extracorporeal Life Support?
- 1 February 2018
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 46 (2) , e181-e182
Is Oxygenation Really an Intrinsic Predictive Factor of Mortality in Patients Undergoing Extracorporeal Life Support?